Abstract
Ghrelin stimulates growth hormone release and cell proliferation, which strongly supports a significant role for this peptide in the control of growth hormone-releasing adenomas function and growth. Nitric oxide can influence the stimulatory effects of ghrelin on growth hormone secretion in growth hormone-releasing adenomas. However, the effect of nitric oxide (NO) on ghrelin-induced cell proliferation and the mechanism of this effect in the adenoma were not clarified. In this study, we observed that ghrelin, at a concentration of 10−9 to 10−6 M, significantly increased BrdU incorporation into rat GH3 cells. A NO donor, S-nitroso-N-acetylpenicillamine (SNAP), blunted basal, and ghrelin-induced cell proliferation. A blocker of NO synthase, Nw-nitro-l-arginine methyl ester hydrochloride (NAME), had no influence on these actions. The activation of extracellular signal-regulated kinase (ERK) 1/2 was examined by western blotting. The results showed that SNAP reduced ghrelin-stimulated ERK1/2 activation but NAME had no influence on this activation. Together, this study indicates that NO inhibited ghrelin-induced cell proliferation by blocking ERK1/2 activation in GH3 cells.
Similar content being viewed by others
References
M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Nature 402(6762), 656–660 (1999)
A.J. van der Lely, M. Tschop, M.L. Heiman, E. Ghigo, Endocr. Rev. 25(3), 426–457 (2004)
A.P. Davenport, T.I. Bonner, S.M. Foord, A.J. Harmar, R.R. Neubig, J.P. Pin, M. Spedding, M. Kojima, K. Kangawa, Pharmacol. Rev. 57(4), 541–546 (2005)
A.D. Howard, S.D. Feighner, D.F. Cully, J.P. Arena, P.A. Liberator, C.I. Rosenblum, M. Hamelin, D.L. Hreniuk, O.C. Palyha, J. Anderson, P.S. Paress, C. Diaz, M. Chou, K.K. Liu, K.K. McKee, S.S. Pong, L.Y. Chaung, A. Elbrecht, M. Dashkevicz, R. Heavens, M. Rigby, D.J. Sirinathsinghji, D.C. Dean, D.G. Melillo, A.A. Patchett, R. Nargund, P.R. Griffin, J.A. DeMartino, S.K. Gupta, J.M. Schaeffer, R.G. Smith, L.H. Van der Ploeg, Science 273(5277), 974–977 (1996)
A.M. Nanzer, S. Kalaf, A.M. Mozid, R.C. Fowkes, M.V. Patel, J.M. Burrin, A.B. Grossman, M. Korbonits, Eur. J. Endocrinol. 151(2), 233–240 (2004)
A. Secondo, R. Sirabella, L. Formisano, A. D’ Alessio, P. Castaldo, S. Amoroso, P. Ingleton, G. Di Renzo, L. Annunziato, J. Neurochem. 84(6), 1367–1377 (2003)
M. Murata, Y. Okimura, K. Iida, M. Matsumoto, H. Sowa, H. Kaji, M. Kojima, K. Kangawa, K. Chihara, J. Biol. Chem. 277(7), 5667–5674 (2002)
D.S. Bredt, P.M. Hwang, S.H. Snyder, Nature 347(6295), 768–770 (1990)
C.G. Chamberlain, K.J. Mansfield, A. Cerra, Mol. Vis. 14, 983–991 (2008)
B.H. Duvilanski, C. Zambruno, A. Seilicovich, D. Pisera, M. Lasaga, M.C. Diaz, N. Belova, V. Rettori, S.M. McCann, Proc. Natl Acad. Sci. USA 92(1), 170–174 (1995)
R. Volpi, P. Chiodera, G. Caffarri, P.P. Vescovi, L. Capretti, C. Gatti, V. Coiro, Neuropeptides 30(6), 528–532 (1996)
F. Rodríguez-Pacheco, R.M. Luque, M. Tena-Sempere, M.M. Malagón, J.P. Castaño, J. Neuroendocrinol. 20(3), 406–412 (2008)
H.P. Chen, L. Zhang, B.H. Xu, L.M. Kang, S.L. Yang, H.H. Zeng, X.Y. Shi, Tissue Cell 41(2), 133–140 (2009)
T. Rubinek, H. Rubinfeld, M. Hadani, G. Barkai, I. Shimon, Endocrine 28(2), 209–216 (2005)
A. Secondo, A. Pannaccione, M. Cataldi, R. Sirabella, L. Formisano, G. Di Renzo, L. Annunziato, Am. J. Physiol. Cell Physiol. 290(1), 233–243 (2006)
M. Candolfi, G. Jaita, V. Zaldivar, S. Zarate, D. Pisera, A. Seilicovich, Neuroendocrinology 80(2), 83–91 (2004)
M. Volante, E. Allia, P. Gugliotta, A. Funaro, F. Broglio, R. Deghenghi, G. Muccioli, E. Ghigo, M. Papptti, J. Clin. Endocrinol. Metab. 87(3), 1300–1308 (2002)
M. Tsumori, Y. Murakami, K. Koshimura, Y. Kato, Endocr. J. 46(6), 779–785 (1999)
M. Tena-Sempere, L. Pinilla, D. Gonzalez, E. Aguilar, Neuroendocrinology 64(2), 146–152 (1996)
C.M. Cuttica, M. Giusti, L. Bocca, P. Sessarego, D. De Martini, S. Valenti, R. Spaziante, G. Giordano, Neuroendocrinology 66(6), 426–431 (1997)
D.H. Wang, Y.S. Hu, J.J. Du, Y.Y. Hu, W.D. Zhong, W.J. Qin, Endocrine 35(1), 112–117 (2009)
M.S. Kim, C.Y. Yoon, P.G. Jang, Y.J. Park, C.S. Shin, H.S. Park, J.W. Ryu, Y.K. Pak, J.Y. Park, K.U. Lee, S.Y. Kim, H.K. Lee, Y.B. Kim, K.S. Park, Mol. Endocrinol. 18(9), 2291–2301 (2004)
J. S. Gutkind, Sci. STKE. 2000(40), re1 (2000)
H. Maekawa, K. Iwabuchi, I. Nagaoka, H. Watanabe, T. Kamano, M. Tsurumaru, Inflamm. Res. 49(10), 541–547 (2000)
G.H. Xue, J.W. Zhang, L. Zhang, H. Zhang, B.G. Zhang, Zhonghua Wai Ke Za Zhi 42(22), 1349–1352 (2004)
D. Maulik, Q.M. Ashraf, O.P. Mishra, M. Delivoria-Papadopoulos, Neurosci. Lett. 439(1), 94–99 (2008)
I. Valverde, A. Penalva, E. Ghigo, F.F. Casanueva, C. Dieguez, Neuroendocrinology 74(4), 213–219 (2001)
C.N. Hall, J. Garthwaite, Nitric Oxide 21(2), 92–103 (2009)
D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, D.A. Wink, Biol. Med. 45(1), 18–31 (2008)
K.S. Madhusoodanan, F. Murad, Neurochem. Res. 32(4–5), 681–694 (2007)
T.S. Kostic, S.A. Andric, S.S. Stojilkovic, Mol. Endocrinol. 15(6), 1010–1022 (2001)
Acknowledgment
The authors acknowledge the support from the National Natural Science Foundation of China, Project No. 30672161.
Author information
Authors and Affiliations
Corresponding author
Additional information
Chunlei Tian and Fei Ye contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tian, C., Ye, F., Wang, L. et al. Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells. Endocr 38, 412–416 (2010). https://doi.org/10.1007/s12020-010-9402-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9402-9